| Autor: |
Lungu O; Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy., Toscani D; Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy., Burroughs-Garcia J; Hematology, Azienda Ospedaliero-Universitaria di Parma, 43126 Parma, Italy., Giuliani N; Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy.; Hematology, Azienda Ospedaliero-Universitaria di Parma, 43126 Parma, Italy. |
| Jazyk: |
angličtina |
| Zdroj: |
International journal of molecular sciences [Int J Mol Sci] 2023 Mar 03; Vol. 24 (5). Date of Electronic Publication: 2023 Mar 03. |
| DOI: |
10.3390/ijms24054893 |
| Abstrakt: |
The study of osteoblast (OB) metabolism has recently received increased attention due to the considerable amount of energy used during the bone remodeling process. In addition to glucose, the main nutrient for the osteoblast lineages, recent data highlight the importance of amino acid and fatty acid metabolism in providing the fuel necessary for the proper functioning of OBs. Among the amino acids, it has been reported that OBs are largely dependent on glutamine (Gln) for their differentiation and activity. In this review, we describe the main metabolic pathways governing OBs' fate and functions, both in physiological and pathological malignant conditions. In particular, we focus on multiple myeloma (MM) bone disease, which is characterized by a severe imbalance in OB differentiation due to the presence of malignant plasma cells into the bone microenvironment. Here, we describe the most important metabolic alterations involved in the inhibition of OB formation and activity in MM patients. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
|
Nepřihlášeným uživatelům se plný text nezobrazuje |
K zobrazení výsledku je třeba se přihlásit.
|
